Taking

RESPIRATORY

THERAPY to NEW PLACES

Drive Medical's Respiratory category has exploded since the acquisitions of CHAD® Therapeutics in 2011 and DeVilbiss Healthcare in 2015. With a new state-of-the-art Respiratory R&D and Testing Facility in Lehigh Acres, FL, Drive is introducing new Respiratory products and programs faster than any manufacturer in the industry.

Quality Products are Our Priority

We proudly research, develop and test our flagship Sleep Therapy and Respiratory products in the United States.

THE STORY OF HOW TECHNOLOGY CAN AFFECT OUTCOMES

Hear Mitch Yoel, Executive Vice President of Business Development at Drive Medical, discuss with HME News the benefits of learning to differentiate between the variety of oxygen conserving device technologies available and matching the right conserving technology to the right patient.

Latest news

The Oxymizer® is the simplest conserving device available today, operating without electronics, batteries or flow controls.

Development of this model of the Oxymizer®draws on over 30 years of research, development, and industry experience. The design of the Oxymizer® provides a more comfortable alternative to high LPM cannulas or non-rebreather masks. Further, it facilitates continued oxygen therapy while patients eat, drink and speak in an unobstructed manner, thereby reducing patient anxiety and the risk of desaturation.